Grafts minimally processed wild-cod skin onto wounds and burns, leveraging its omega-3-rich structure to recruit the body's own cells for tissue regeneration without synthetic materials.
Kerecis's work centers on Fish-Skin Grafts, Wound Care, and Tissue Engineering, placing it among the BioTech companies building in the Nordic region. Founded in 2009 and now operating at a 201-500-employee scale, Kerecis sits in the scaleup stage of its growth. Within the directory, Kerecis is one of 3 BioTech companies tracked across the Nordics, based in Isafjordur.
Kerecis is headquartered in Isafjordur, Iceland.
Grafts minimally processed wild-cod skin onto wounds and burns, leveraging its omega-3-rich structure to recruit the body's own cells for tissue regeneration without synthetic materials.
Kerecis was founded in 2009.
Kerecis has approximately 201-500 employees.
Kerecis operates in BioTech, specializing in Fish-Skin Grafts, Wound Care, Tissue Engineering.